Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 16
Submit an article Journal homepage
632
Views
23
CrossRef citations to date
0
Altmetric
Original Research

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

Ubaldo BonuccelliUniversity of Pisa, Department of Neurosciences, Pisa, Italy+39 050 992564; +39 050 993145; [email protected]
,
Giuseppe MecoLa Sapienza University, Research Centre of Social Diseases (CIMS), Department of Neurology and Psychiatry, Rome, Italy
,
Giovanni FabbriniLa Sapienza University, Neuromed Institute, Department of Neurology and Psychiatry, Rome, Italy
,
Alessandro TessitoreII University of Naples, Department of Neurological Sciences, Naples, Italy
,
Mariangela PierantozziTor Vergata University of Rome, Department of Neurosciences, Rome, Italy
,
Fabrizio StocchiDepartment of Neurology, IRCCS San Raffaele Pisana, Rome, Italy
,
Roberto CeravoloIRCCS Roma Santa Lucia, Rome, Italy
,
Carlo CaltagironeTor Vergata University of Rome, Department of Neurosciences, Rome, Italy;IRCCS Roma Santa Lucia, Rome, Italy
,
Mauro SilvestriniPolytechnic University of Marche, Neurologic Clinic, Ancona, Italy
,
Francesca MorganteUniversity of Messina, Department of Neurosciences, Psychiatric and Anaesthesiologic Sciences, Messina, Italy
,
Stefano RuggieriIRCCS Pozzilli, Isernia, Italy
,
Laura AvanzinoUniversity of Genoa, Department of Neurosciences, Ophthalmology and Genetics, Genoa, Italy
,
Michele GuadagnaMedical Department, Eli Lilly Italia S.p.A, Sesto Fiorentino (FI), Italy
,
Grazia Dell'AgnelloMedical Department, Eli Lilly Italia S.p.A, Sesto Fiorentino (FI), Italy
,
Andrea RossiMedical Department, Eli Lilly Italia S.p.A, Sesto Fiorentino (FI), Italy
,
Riccardo SpeziaCROS NT, Verona, Italy
&
Michele ManciniMedical Department, Eli Lilly Italia S.p.A, Sesto Fiorentino (FI), Italy
 show all
Pages 2269-2280 | Published online: 15 Oct 2012

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Isabella Berardelli, Daniele Belvisi, Massimo Pasquini, Andrea Fabbrini, Federica Petrini & Giovanni Fabbrini. (2019) Treatment of psychiatric disturbances in hypokinetic movement disorders. Expert Review of Neurotherapeutics 19:10, pages 965-981.
Read now
Melody Ryan, Courtney V. Eatmon & John T. Slevin. (2019) Drug treatment strategies for depression in Parkinson disease. Expert Opinion on Pharmacotherapy 20:11, pages 1351-1363.
Read now
Chi-Un Pae. (2013) Use of antidepressants for depression in patients with Parkinson's disease. Expert Opinion on Pharmacotherapy 14:3, pages 255-257.
Read now

Articles from other publishers (20)

Weijing Yang, Xue Qiu, Qinghua Wu, Fei Chang, Tao Zhou, Mingmei Zhou & Jin Pei. (2023) Active constituents of saffron (Crocus sativus L.) and their prospects in treating neurodegenerative diseases (Review). Experimental and Therapeutic Medicine 25:5.
Crossref
Mir Hilal Ahmad, Moshahid Alam Rizvi, Mansoor Ali & Amal Chandra Mondal. (2023) Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Research Reviews 85, pages 101840.
Crossref
Xiao-Le Wang, Si-Tong Feng, Ya-Ting Wang, Bin Chen, Zhen-Zhen Wang, Nai-Hong Chen & Yi Zhang. (2022) Comparative efficacy and acceptability of drug treatments for Parkinson’s disease with depression: A systematic review with network meta-analysis. European Journal of Pharmacology 927, pages 175070.
Crossref
R. Bhome, A. Zarkali, G. E. C. Thomas, J. E. Iglesias, J. H. Cole & R. S. Weil. (2022) Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression. npj Parkinson's Disease 8:1.
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 777 830 .
Bing Hu. 2021. The Neuroscience of Depression. The Neuroscience of Depression 357 368 .
Hirotaka Iwaki, Rina Ando, Satoshi Tada, Noriko Nishikawa, Tomoaki Tsujii, Yuki Yamanishi, Noriyuki Miyaue, Hayato Yabe, Masahiro Nagai & Masahiro Nomoto. (2020) A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease. Journal of the Neurological Sciences 414, pages 116833.
Crossref
Jian-Yong Wang, Qian-Ya Fan, Jia-Hui He, Shi-Guo Zhu, Chen-Ping Huang, Xiong Zhang & Jian-Hong Zhu. (2019) SLC6A4 Repeat and Single-Nucleotide Polymorphisms Are Associated With Depression and Rest Tremor in Parkinson's Disease: An Exploratory Study. Frontiers in Neurology 10.
Crossref
Makio Takahashi, Hayato Tabu, Akihiko Ozaki, Toshiaki Hamano & Takao Takeshima. (2019) Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study. Internal Medicine 58:3, pages 361-368.
Crossref
Ankur Butala, Melissa Shepard & Greg Pontone. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease 83 121 .
E. Peña, M. Mata, L. López-Manzanares, M. Kurtis, M. Eimil, J.C. Martínez-Castrillo, I. Navas, I.J. Posada, C. Prieto, C. Ruíz-Huete, L. Vela & B. Venegas. (2018) Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid. Neurología (English Edition) 33:6, pages 395-402.
Crossref
E. Peña, M. Mata, L. López-Manzanares, M. Kurtis, M. Eimil, J.C. Martínez-Castrillo, I. Navas, I.J. Posada, C. Prieto, C. Ruíz-Huete, L. Vela & B. Venegas. (2018) Antidepresivos en la enfermedad de Parkinson. Recomendaciones del grupo de trastornos del movimiento de la Asociación Madrileña de Neurología. Neurología 33:6, pages 395-402.
Crossref
Haruo Nishijima, Tatsuya Ueno, Tomoya Kon, Rie Haga, Yukihisa Funamizu, Akira Arai, Chieko Suzuki, Jin-ichi Nunomura, Masayuki Baba & Masahiko Tomiyama. (2017) Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience. Journal of the Neurological Sciences 375, pages 186-189.
Crossref
Yannick Vermeiren & Peter P. De Deyn. (2017) Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story. Neurochemistry International 102, pages 22-32.
Crossref
Haruo Nishijima, Tatsuya Ueno, Shinya Ueno & Masahiko Tomiyama. (2016) Duloxetine increases the effects of levodopa in a rat model of Parkinson's disease. Neurology and Clinical Neuroscience 4:4, pages 129-133.
Crossref
Maritza Sandoval-Rincón, Michel Sáenz-Farret, Adán Miguel-Puga, Federico Micheli & Oscar Arias-Carrión. (2015) Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease. Frontiers in Neurology 6.
Crossref
Philippe Huot, Susan H. Fox & Jonathan M. Brotchie. (2015) Monoamine Reuptake Inhibitors in Parkinson’s Disease. Parkinson's Disease 2015, pages 1-71.
Crossref
Alberto J. Espay, Peter A. LeWitt & Horacio Kaufmann. (2014) Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement. Movement Disorders 29:14, pages 1710-1719.
Crossref
Jack J. Chen & Laura Marsh. (2013) Depression in Parkinson's Disease: Identification and Management. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:9, pages 972-983.
Crossref
Johan LökkSeyed-Mohammad Fereshtehnejad. (2013) Managing palliative care in Parkinson’s disease from diagnosis to end-stage disease: what the clinician should know. Neurodegenerative Disease Management 3:2, pages 169-183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.